Ontology highlight
ABSTRACT: Purpose of review
The current treatment options for advanced urologic cancers demonstrate limited efficacy. To obtain optimal clinical results, there is a need for new, individualized, therapeutic strategies, which have only recently been applied to these malignancies. Nuclear medicine plays an important role in establishing imaging biomarkers necessary for personalized medicine. This review focuses on the current status of the 'image and treat' approach combining molecular imaging with targeted radionuclide therapy of urological malignanciesRecent findings
Tumor-specific targets in uro-oncology are showing promising results for development of personalized therapy using positron emission tomography/computed tomography (PET/CT) molecular imaging and radioimmunotherapy. The a
SUBMITTER: Bouchelouche K
PROVIDER: S-EPMC2855391 | biostudies-literature | 2010 May
REPOSITORIES: biostudies-literature